AMG
38
2
STI
58
20
GS
79
3
MAT
51
4
BSX
69
-2
MAS
62
2
FMC
43
4
MOS
19
-6
MPC
30
-9
AME
57
-6
OMC
65
7
FTI
84
3
SYY
50
2
AVB
69
4
ADP
57
-7
HCP
82
-2
MCO
73
2
GPC
54
-2
HBI
25
4
DNB
32
8
AMG
38
2
STI
58
20
GS
79
3
MAT
51
4
BSX
69
-2
MAS
62
2
FMC
43
4
MOS
19
-6
MPC
30
-9
AME
57
-6
OMC
65
7
FTI
84
3
SYY
50
2
AVB
69
4
ADP
57
-7
HCP
82
-2
MCO
73
2
GPC
54
-2
HBI
25
4
DNB
32
8
Financhill
Back

Cryo-Cell International 10K Form

Buy
63

CCEL
Cryo-Cell International

Last Price:
8.57
Seasonality Move:
15.44%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CCEL News And Ratings

See the #1 stock for the next 7 days that we like better than CCEL

CCEL Financial Statistics

Sales & Book Value

Annual Sales: $31.34M
Cash Flow: $-814.6K
Price / Cash Flow: 0
Annual Sales: $-1.25
Price / Book: 0

Profitability

EPS (TTM): -1.16260
Net Income (TTM): $-9.73M
Gross Margin: $22.9M
Return on Equity: 0%
Return on Assets: -14.85%

Cryo-Cell International Earnings Forecast

Key Cryo-Cell International Financial Ratios

  • The Gross Profit Margin over the past 28 years for CCEL is 73.07%.
  • The Selling, General & Administrative Expenses for CCEL have been equal to 54.61% of Gross Profit Margin.
  • The Research & Development expenses have been 3.74% of Revenue.
  • The Interest Expense is -12.99% of Operating Income.
  • The Net Earning history of CCEL is -30.38% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 13 years.

Cryo-Cell International Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CCEL
Website: cryo-cell.com

Debt

Debt-to-Equity Ratio: -1.02
Current Ratio: 0.49
Quick Ratio: 0.4

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 40.81

CCEL Technical Analysis vs Fundamental Analysis

Buy
63
Cryo-Cell International (CCEL) is a Buy

Is Cryo-Cell International a Buy or a Sell?